Delivery Order SPE2DB25D3017-SPE2DB25FVKKE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Advair HFA 115-21 mcg inhalers (12 gm) valued at $1,358.22, with an ultimate completion date of May 5, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 gm) valued at $1,745.46 under a firm fixed price contract type. The award was made on September 23, 2025, with an ultimate completion date of September 24, 2025, and represents a non-competitive, non-set-aside procurement. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $11,601.36 to AmerisourceBergen Drug Corp for Advair HFA 230-21 microgram inhalers (12 grams) under a firm fixed price contract, with an ultimate completion date of September 3, 2025. This non-set-aside competitive award represents a pharmaceutical supply delivery to support federal medical procurement needs. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $13,747.80 to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 gm) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child order under AmerisourceBergen's larger contract vehicle with the DLA. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Advair HFA 115-21 microgram inhalers (12 gram units) with a ceiling value of $1,476.11. This is a firm fixed price delivery order with an ultimate completion date of August 1, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $1,438.62 to AmerisourceBergen Drug Corp for Advair HFA 115-21 mcg inhalers (12 grams) on September 15, 2025, with completion expected by September 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this established pharmaceutical distributor. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $2,965.10 delivery order to AmerisourceBergen Drug Corp on April 25, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 grams). This competitively awarded, firm fixed-price delivery order is scheduled for completion by April 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed openly among qualified vendors. This delivery...
- The Defense Logistics Agency awarded a $19,014.36 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gm units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,260.90 to AmerisourceBergen Drug Corp for Advair HFA 45-21 mcg inhalers (12 grams) with an ultimate completion date of September 19, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through an open procurement process. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $5,105.61 to AmerisourceBergen Drug Corp for Advair HFA 230-21 microgram inhalers (12-gram units) with an ultimate completion date of August 26, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract represents a...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB25FVKKEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Advair HFA 230-21 MCG inhalers (12 GM) valued at $3,052.67, with an ultimate completion date of August 27, 2025. This non-competitive delivery order was issued under a firm fixed-price contract type and represents a routine pharmaceutical supply procurement supporting federal healthcare needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen is a major pharmaceutical distributor and critical federal vendor that consistently demonstrates capability to fulfill open competition federal procurement requirements across multiple therapeutic domains and customer bases including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 8/26/25 |